Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Cash from Investing Activities came in at -$13.1 million in Q1 2026, down 203.73% year-on-year from $12.6 million in Q1 2025, and up 22.01% on a QoQ basis from -$16.8 million in Q4 2025.
Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Cash from Investing Activities data on file, last reported at -$13.1 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 203.73% year-over-year to -$13.1 million in Q1 2026; TTM through Mar 2026 was -$73.7 million, a 63.51% increase from a year earlier, with the FY2025 full-year figure at -$64.9 million, up 67.55% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$13.1 million, up from -$16.8 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for LMAT reached as high as -$402000.0 in Q4 2022 and fell as low as -$173.9 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$18.4 million across 5 years, with a median of -$9.6 million in 2023.
- Across the five-year window, Cash from Investing Activities soared 94.45% in 2022 and tumbled 7590.93% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$402000.0 in 2022, then sank by 462.44% to -$2.3 million in 2023, then tumbled by 7590.93% to -$173.9 million in 2024, then soared by 90.32% to -$16.8 million in 2025, then grew by 22.01% to -$13.1 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$13.1 million in Q1 2026, -$16.8 million in Q4 2025, and -$27.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Lemaitre Vascular | 2.25 Bn | 1.88 Bn | 48.40 Mn | -13.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.12 Mn |
| Mar 31, 2026 | -13.12 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Sep 30, 2025 | -27.45 Mn |
| Sep 30, 2025 | -27.45 Mn |
| Jun 30, 2025 | -16.35 Mn |
| Jun 30, 2025 | -16.35 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -173.89 Mn |
| Dec 31, 2024 | -173.89 Mn |
| Sep 30, 2024 | -12.86 Mn |
| Sep 30, 2024 | -12.86 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -2.36 Mn |
| Mar 31, 2024 | -2.36 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Dec 31, 2023 | -2.26 Mn |